Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

BUY
$36.57 - $58.29 $863,125 - $1.38 Million
23,602 New
23,602 $1.31 Million
Q1 2022

May 09, 2022

SELL
$30.32 - $91.33 $777,617 - $2.34 Million
-25,647 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$86.26 - $119.0 $23,721 - $32,725
-275 Reduced 1.06%
25,647 $2.4 Million
Q3 2021

Nov 09, 2021

SELL
$100.17 - $126.36 $343,482 - $433,288
-3,429 Reduced 11.68%
25,922 $2.89 Million
Q2 2021

Aug 12, 2021

SELL
$86.05 - $119.72 $892,338 - $1.24 Million
-10,370 Reduced 26.11%
29,351 $3.33 Million
Q1 2021

May 12, 2021

SELL
$91.47 - $124.36 $743,559 - $1.01 Million
-8,129 Reduced 16.99%
39,721 $4.03 Million
Q4 2020

Feb 12, 2021

SELL
$66.66 - $111.74 $656,067 - $1.1 Million
-9,842 Reduced 17.06%
47,850 $4.76 Million
Q3 2020

Nov 12, 2020

SELL
$45.89 - $72.67 $377,582 - $597,928
-8,228 Reduced 12.48%
57,692 $4.17 Million
Q2 2020

Aug 04, 2020

SELL
$26.36 - $49.86 $118,699 - $224,519
-4,503 Reduced 6.39%
65,920 $3.29 Million
Q1 2020

May 04, 2020

SELL
$17.27 - $40.17 $195,133 - $453,880
-11,299 Reduced 13.83%
70,423 $2.1 Million
Q4 2019

Feb 10, 2020

SELL
$32.1 - $40.4 $335,188 - $421,856
-10,442 Reduced 11.33%
81,722 $2.75 Million
Q3 2019

Oct 22, 2019

SELL
$25.38 - $34.89 $277,479 - $381,452
-10,933 Reduced 10.6%
92,164 $3.02 Million
Q2 2019

Aug 15, 2019

SELL
$17.75 - $27.58 $822,428 - $1.28 Million
-46,334 Reduced 31.01%
103,097 $2.84 Million
Q1 2019

May 15, 2019

BUY
$11.34 - $20.62 $259,969 - $472,713
22,925 Added 18.12%
149,431 $3.08 Million
Q4 2018

Feb 06, 2019

BUY
$12.32 - $24.38 $48,195 - $95,374
3,912 Added 3.19%
126,506 $1.77 Million
Q3 2018

Oct 16, 2018

SELL
$18.82 - $28.96 $973,295 - $1.5 Million
-51,716 Reduced 29.67%
122,594 $2.94 Million
Q2 2018

Jul 17, 2018

BUY
$8.79 - $19.98 $1.53 Million - $3.48 Million
174,310 New
174,310 $3.28 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.